注射用盐酸万古霉素致急性药物性肝损伤1例分析

doi:10.19803/j.1672-8629.2021.08.20

中国药物警戒 ›› 2021, Vol. 18 ›› Issue (8): 789-792.
DOI: 10.19803/j.1672-8629.2021.08.20

注射用盐酸万古霉素致急性药物性肝损伤1例分析

梁瑜, 孟真, 仓怀芹, 李祥鹏, 倪倍倍, 纪洪艳^*

青岛大学附属医院,山东青岛 266000

收稿日期:2019-12-26 出版日期:2021-08-15 发布日期:2021-08-17
通讯作者: ^*纪洪艳,女,本科,主管药师,临床药学。E-mail：70501477@qq.com
作者简介:梁瑜,女,硕士,主管药师,临床药学。

Acute Drug-Induced Liver Injury Caused by Vancomycin Hydrochloride for Injection: One Case Report

LIANG Yu, MENG Zhen, CANG Huaiqin, LI Xiangpeng, NI Beibei, JI Hongyan^*

The Affiliated Hospital of Qingdao University, Qingdao Shandong 266000, China

Received:2019-12-26 Online:2021-08-15 Published:2021-08-17

摘要/Abstract

摘要： 目的通过分析注射用盐酸万古霉素导致急性药物性肝损伤的严重药品不良反应,为临床安全合理用药提供借鉴。方法以1例颅脑术后肝损伤患者为例,分析患者诊治经过查找患者肝损伤的原因,并采用因果关系评价标准表评估可能引起肝损伤的药物。结果该患者转氨酶水平显著升高可能与万古霉素有关,考虑为万古霉素导致的急性药物性肝损伤。结论医师和药师在使用万古霉素时除关注患者肾功能外,还应重点关注患者的肝功能,如患者出现肝功能损伤,应警惕万古霉素诱发的严重药品不良反应。

关键词: 万古霉素, 药物性肝损伤, 药品不良反应

Abstract: Objective To analyze such severe adverse reactions as acute drug-induced liver injury caused by vancomycin hydrochloride. Methods One case of liver injury after craniocerebral surgery was investigated. The cause of liver injury was identified by analyzing the diagnosis and treatment of the patient, and the suspected drug was evaluated by the RUCAM scale. Results The significantly elevated transaminase level in this patient might have been related to vancomycin, which was considered to have caused the acute drug-induced liver injury. Conclusion When using vancomycin, physicians and pharmacists should pay attention to the liver function and renal function of patients. In case of liver injury, they should be alert to the serious adverse reactions caused by vancomycin.

Key words: vancomycin, drug-induced liver injury, adverse drug reaction

中图分类号:

R994.1

梁瑜, 孟真, 仓怀芹, 李祥鹏, 倪倍倍, 纪洪艳. 注射用盐酸万古霉素致急性药物性肝损伤1例分析[J]. 中国药物警戒, 2021, 18(8): 789-792.

LIANG Yu, MENG Zhen, CANG Huaiqin, LI Xiangpeng, NI Beibei, JI Hongyan. Acute Drug-Induced Liver Injury Caused by Vancomycin Hydrochloride for Injection: One Case Report[J]. Chinese Journal of Pharmacovigilance, 2021, 18(8): 789-792.

参考文献

[1] Daniel SM, Gisele H, Bruno F, et al.The study of vancomycin use and its adverse reactions associated to patients of a brazilian university hospital[J]. BMC Research Notes, 2011, 15(4): 236-242.
[2] Bruniera FR, Ferreira FM, Saviolli LRM, et al.The use of vanco-mycin with its therapeutic and adverse effects: a review[J]. European Review for Medical Pharmacological Sciences, 2015, 19(4): 694-700.
[3] Wang DX, Zhu M, Guo DH, et al.Analysis on 930 cases of ADR/ADE associated with glycopeptides and oxazolidinone antibacterials from military hospitals[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2017, 14(1): 37-41.
[4] Zeng JY, Chen X.Pay attention to vancomycin-related nephrotoxicity and its prevention[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2018, 20(2): 81-82.
[5] Liu LY, Li Y, Gu SY.Retrospective analysis of 38 granulocytopenia cases induced by vancomycin[J]. Chinese Journal of Pharmac-ovigilance(中国药物警戒), 2012, 9(2): 117-118.
[6] Mohammadi M, Jahanqard-Rafsanjani Z, Sarayani A, et al.Vancomycin-induced thrombocytopenia: a narrative review[J]. Drug Safety, 2017, 40(1): 49-59.
[7] Zhao CL, Pei H, Zhao BH, et al.Literature analysis of 95 cases of adverse drug reactions induced by vancomycin[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(6):354-358.
[8] Li CH, Jin J.Pathogenesis and clinical characteristics of liver injury caused by antibiotics[J]. Herald of Medicine(医药导报), 2016, 35(S1): 76-78.
[9] Wang QX.A case of adverse reaction of acute renal damage caused by vancomycin and literature review[J]. Chinese Journal of Clinical Pharmacy(中国临床药学杂志), 2016, 25(5): 316-318.
[10] Qin N, You YM, Zhang CL, et al.A case of acute liver injury caused by vancomycin[J].Chinese Journal of Clinicians(中华临床医师杂志), 2013, 7(21): 9818-9819.
[11] Cadle RM, Mansouri MD, Darouiche RO.Vancomycin-induced elevation of liver enzyme level[J]. Annals of Pharmacotherapy, 2006, 40(6): 1186-1189.
[12] Zhang XW, Xie JF, Cai SX, et al.Research progress in liver dysfunction related to systemic infection[J]. Chinese Journal of Surgery(中华外科杂志), 2014, 52(6):455-457.
[13] Zhang HX, Wu XZ, Yang CQ, et al.Study on the correlation between liver function damage and severity and prognosis of patients with sepsis[J]. Laboratory Medicine and Clinic(检验医学与临床), 2015, 12(2): 204-206.
[14] Zhu WH, Qin Y, Wang CZ, et al.The clinical significance of serum bilirubin level on the prognosis of patients with sepsis[J]. Journal of Internal Intensive Medicine(内科急危重症杂志), 2019, 25(3): 234-263.
[15] Luan ZG, Ma XC.Sepsis-related liver damage[J]. Chinese Journal of Practical Surgery(中国实用外科杂志), 2012, 32(11): 959-965.
[16] Yang MM, Ren J, Heng Y, et al.Role of clinical pharmacists in the prevention and treatment of drug-induced liver injury[J]. China Pharmacy(中国药房), 2015, 26(2): 264-266.
[17] Yu LC, Mao YM, Chen CW.Guidelines for diagnosis and treatment of drug-induced liver injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2015, 31(11): 1752-1769.
[18] Wang Y, Ye ZK, Cui XL, et al.Pharmaceutical care of a patient with liver injury induced by omeprazole or octreotide[J]. Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2017, 33(19): 1959-1960.
[19] Wu YT.One case of drug-induced liver injury caused by merope-nem[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2017, 14(1): 66-68.
[20] Liu B, Ma G.Study progress in antibacterial drug induced liver injury[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2016, 36(9): 778-784.
[21] Bai XR, Chu YQ.Role of clinical pharmacist intervention in therapeutic drug monitoring of vancomycin[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(7): 439-443.
[22] Yang MM, Chen ZZ, Ren J, et al.Pharmaceutical care of a case of acute liver injury caused by antibiotics[J]. Herald of Medicine(医药导报), 2015, 34(7): 972-974.

注射用盐酸万古霉素致急性药物性肝损伤1例分析

Acute Drug-Induced Liver Injury Caused by Vancomycin Hydrochloride for Injection: One Case Report

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[4]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[5]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[6]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[7]	曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218.
[8]	王欣, 史磊磊, 张雨涵, 谢允东, 刘继平. 多药耐药相关蛋白转运体在药物性肝损伤中的作用研究进展[J]. 中国药物警戒, 2024, 21(2): 229-234.
[9]	高云娟, 赵旭, 白天凯, 柏兆方, 王伽伯, 宋海波, 肖小河. 基于不良反应监测大数据的药品安全风险发现与识别策略[J]. 中国药物警戒, 2024, 21(1): 1-5.
[10]	郭龙鑫, 高云娟, 吴承钊, 龙敏娟, 祝胜凯, 宋海波, 赵旭, 肖小河. 基于不良反应监测大数据的中药药源性肝损伤风险信号新发现及易感因素初探[J]. 中国药物警戒, 2024, 21(1): 15-19.
[11]	高源, 石伟, 肖小河, 柏兆方, 王伽伯. 特异质型药物性肝损伤体内评价模型研究进展[J]. 中国药物警戒, 2024, 21(1): 33-39.
[12]	蒋文硕, 杨莉. 694例癫痫医师药师联合门诊患者药品不良反应分析[J]. 中国药物警戒, 2024, 21(1): 102-106.
[13]	陈华炎, 江东波, 郭春连, 杨家琪, 黎雨欣, 蔡伟明. 326例奈玛特韦片/利托那韦片治疗新型冠状病毒感染安全性分析[J]. 中国药物警戒, 2024, 21(1): 107-110.
[14]	詹姆斯·布坎南. 用 nR 改良海氏法则及 P_ALT 评估药物性肝损伤研究进展[J]. 中国药物警戒, 2024, 21(1): 117-120.
[15]	刘赛月, 吕小琴, 周耘. 疑似药品不良反应死亡病例调查及报告实施要点[J]. 中国药物警戒, 2023, 20(9): 971-974.